David H. Fater
Chairman, President, Chief Executive Officer, Director
Joining Vicor in 2002, Mr. Fater serves as Chairman, President, Chief Executive Officer.
Mr. Fater is also the founder and Chief Executive Officer of ALDA & Associates International Inc., a business and financial consulting firm providing capital formation, capital allocation, and profit optimization services to small companies, primarily in the health care and life sciences industries. Since ALDA’s formation in 1993, Mr. Fater has worked with more than 50 entrepreneur-founded companies. As a company senior executive, he led BMJ Medical Management, Inc. (1997-1999) and Community Care of America (1995-1996) through the IPO process, and led Coastal Physician Group, Inc. (1993-1995) to a NYSE listing and $1.0 billion market capitalization.
Prior to forming ALDA & Associates, Mr. Fater was employed by Ernst & Young. He completed his 24-year tenure as a Senior International Partner advising senior management and boards of directors (1969-1992).
Mr. Fater is a Certified Public Accountant in Georgia, Illinois, North Carolina, and New York. He holds a BS in Accounting from the University of North Carolina.
James E. Skinner, PhD
Vice President, Director of Grant Research, Director
Joining Vicor in August, 2000, Dr. Skinner has extensive experience both as a scientist and manager of large research and development projects. He is the Director of the Delaware Water Gap Science Institute, a non-profit medical research organization devoted to the development of medical devices and pharmaceuticals. Prior to founding the Delaware Water Gap Science Institute, Dr. Skinner was Associate Director of Totts Gap Medical Research Laboratories, Inc. (1969-1997). Earlier, he was a Professor and Researcher at Baylor College of Medicine in Houston (1969-1993) and recipient of numerous research grants from the National Institutes of Health.
Dr. Skinner holds a PhD in Neuroscience from the University of California at Los Angeles and a BA in Pre-Med, Physics, and Physiological Psychology from Pomona College.
Jerry M. Anchin, PhD
Vice President, Director of Product Development
Dr. Anchin has more than 30 years of experience in the fields of immunology, molecular biology, drug discovery, and protein chemistry. Prior to joining Vicor in 2000, Dr. Anchin was employed by Ciblex Pharmaceuticals (1998-2000), where he became group leader of the drug discovery program that led to the discovery of novel small molecules used in the prevention of asthma. Earlier, he held positions at Prism Pharmaceuticals (1996-1998), and Immuno Pharmaceuticals (1993-1996). Before that, he was Head of Assay Development and Manufacturing at International Immunoassay Labs (1991-1998), where he was instrumental in designing a novel assay for the detection of the protein creatine kinase released during acute myocardial infarction.
Dr. Anchin holds patents for 14 immunoassay and drug discovery platforms; he has an additional 16 patents pending. Dr. Anchin earned a PhD in Immunology from Texas A&M University and a BA in Cell Biology from the University of California at Santa Barbara.
Daniel N. Weiss, MD, FACC
Chief Medical Officer
With Vicor since 2004, Dr. Weiss has extensive experience in the practice of cardiology and electrophysiology. Dr. Weiss is a partner with Florida Arrythmia Consultants and a former director of the Jim Moran Heart and Vascular Center. He has served as a consultant to Fortune 500 medical device manufacturers, including Medtronics, St. Jude Medical, and Guidant. He also served as the clinical investigator on the two most important clinical trials involving the study of ICDs and SCD (MADIT-II (MultiCenter Automatic Defibrillator Implantation Trial) and SCD HeFT (Sudden Cardiac Death Heart Failure Trial).
Dr. Weiss received a MD with Distinction in Research from the Mount Sinai School of Medicine, from which he also received the Nathan A. Setz Award for Research in Cardiovascular and Renal Disease. He holds a BSE cum laude in Electrical Engineering and Computer Science from Princeton University.
Richard M. Cohen
Vice President of Corporate and Business Development, Chief Operating Officer
Richard Cohen was appointed to serve as Vice President of Business Development on January 1, 2008. Since 2001, Mr. Cohen has been the Chief Operating Officer of ALDA & Associates International, Inc., a business and consulting firm providing capital formation, capital allocation, and profit optimization services to small companies, primarily in the healthcare and life sciences industries. In his capacity as ALDA’s Chief Operating Officer and in connection with certain consulting engagements, Mr. Cohen has served as the Chief Executive Officer of two healthcare companies and two medical device companies. He has more than 30 years of experience in international manufacturing and operations, predominantly in the Far East and South America.
Mr. Cohen holds a BS in Business Marketing from Kentucky Wesleyan University.
Thomas J. Bohannon
Chief Financial Officer, Chief Accounting Officer
Mr. Bohannon was appointed to serve as the Chief Accounting Officer of the Company effective December 28, 2008. Mr. Bohannon has been in the accounting and financial field for more than 40 years. Prior to joining Vicor, Mr. Bohannon ran an independent consulting practice from which he served as financial officer for a variety of companies in the Southeast United States. Earlier, he was partner in charge of audit and review services for Pappadakis, Nelson & Bohannon (1978—1991). Before that, he was a senior manager specializing in financial and SEC reporting at Ernst & Young in Atlanta.
